Header Logo

Connection

GUEORGUI DUBROCQ to HIV-1

Back to Details
This is a "connection" page, showing publications GUEORGUI DUBROCQ has written about HIV-1.
GUEORGUI DUBROCQ
Connection Strength
0.106
HIV-1
  1. The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection. Expert Opin Drug Metab Toxicol. 2018 Aug; 14(8):773-779.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.